首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1685656

2025-2029年全球核子醫學市場

Global Nuclear Medicine Market 2025-2029

出版日期: 2025年03月14日 | 出版商:

TechNavio | 英文 201 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

預計從 2024 年到 2029 年，核醫市場將成長 130.119 億美元，預測期內的複合年成長率為 19.2%。

本報告對核醫市場進行了全面的分析，包括市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場情景、最新趨勢和促進因素以及整體市場環境的最新分析。推動市場發展的因素包括 SPECT/CT 混合影像系統的日益普及、核醫學在疾病早期檢測中的應用日益廣泛、癌症患者數量日益增多以及腫瘤學市場投資日益增加。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
2025與前一年同期比較	16.1%
複合年成長率	19.2%
增量金額	130.119億美元

研究採用客觀結合一手資料和二手資料的方式進行，其中包括來自業界主要參與者的意見。該報告包括全面的市場規模資料（按地理分析細分）和供應商格局以及對主要企業的分析。該報告包括資料和預測資料。

研究指出，與潛在益處相比，放射性藥物的副作用極小，這是推動未來幾年核醫市場成長的主要原因之一。此外，活性化混合成像應用的研究活動以及新放射性藥物的不斷發現和開發將導致市場需求龐大。

地理細分
區域比較
北美：2024-2029 年市場規模及預測
亞洲：2024-2029 年市場規模及預測
歐洲：2024-2029 年市場規模及預測
世界其他地區：2024-2029 年市場規模及預測
美國：市場規模及預測（2024-2029）
中國：2024-2029年市場規模及預測
日本：2024-2029 年市場規模及預測
加拿大：2024-2029 年市場規模及預測
印度：2024-2029 年市場規模及預測
英國：2024-2029 年市場規模及預測
韓國：2024-2029 年市場規模及預測
德國：2024-2029年市場規模及預測
澳洲：2024-2029 年市場規模及預測
法國：2024-2029年市場規模及預測
按地區分類的市場機會

第12章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第13章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第14章競爭分析

公司簡介
企業排名指數
公司市場定位
Bayer AG
Bracco Spa
Cardinal Health Inc.
Eckert and Ziegler AG
ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
GE Healthcare Technologies Inc.
IBA Radiopharma Solutions
Jubilant Pharmova Ltd.
Koninklijke Philips NV
Mallinckrodt Plc
Medi-Radiopharma
Necsa
Novartis AG
Siemens Healthineers AG
Sirtex Medical Pty Ltd.

第15章附錄

簡介目錄圖表

Product Code: IRTNTR75093

The nuclear medicine market is forecasted to grow by USD 13011.9 million during 2024-2029, accelerating at a CAGR of 19.2% during the forecast period. The report on the nuclear medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of SPECT/CT hybrid imaging systems, rising utilization of nuclear medicine for early disease detection, and growing cancer cases and rising investment in oncology market.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	16.1%
CAGR	19.2%
Incremental Value	$13011.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's nuclear medicine market is segmented as below:

By Product

Radiotherapeutics
Equipment (SPECT and PET)

By Application

Oncology
Cardiology
Neurology
Others

By Geographical Landscape

North America
Asia
Europe
Rest of World (ROW)

This study identifies the minimal side effects of radiopharmaceuticals as compared with its potential benefits as one of the prime reasons driving the nuclear medicine market growth during the next few years. Also, growing research activities to widen applications of hybrid imaging and constant discovery and development of new radiopharmaceuticals will lead to sizable demand in the market.

The report on the nuclear medicine market covers the following areas:

Nuclear Medicine Market sizing
Nuclear Medicine Market forecast
Nuclear Medicine Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading nuclear medicine market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Eckert and Ziegler AG, ECZACIBASI MONROL NUCLEAR PRODUCTS CO., GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Pharmova Ltd., Koninklijke Philips NV, Lantheus, Mallinckrodt PLC, Medi-Radiopharma, Mirion Technologies Inc., Necsa, Novartis AG, Siemens Healthineers AG, Sirtex Medical Pty Ltd., Telix Pharmaceuticals Ltd., Tema Sinergie SpA, and TTG Imaging Solutions LLC. Also, the nuclear medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Nuclear Medicine Market 2019 - 2023
- Historic Market Size - Data Table on Global Nuclear Medicine Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact of AI on the Global Nuclear Medicine Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Radiotherapeutics - Market size and forecast 2024-2029
- Chart on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
- Data Table on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
- Chart on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
8.4 Equipment (SPECT and PET) - Market size and forecast 2024-2029
- Chart on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
- Data Table on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
- Chart on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
- Data Table on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Application

9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
9.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
9.4 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
9.5 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.9 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.11 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.12 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.13 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
11.14 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.15 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
11.16 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
14.5 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
- SWOT
14.6 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
14.7 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
14.8 ECZACIBASI MONROL NUCLEAR PRODUCTS CO.
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
- ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
- SWOT
14.9 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
14.10 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
14.11 Jubilant Pharmova Ltd.
- Jubilant Pharmova Ltd. - Overview
- Jubilant Pharmova Ltd. - Business segments
- Jubilant Pharmova Ltd. - Key news
- Jubilant Pharmova Ltd. - Key offerings
- Jubilant Pharmova Ltd. - Segment focus
- SWOT
14.12 Koninklijke Philips NV
- Koninklijke Philips NV - Overview
- Koninklijke Philips NV - Business segments
- Koninklijke Philips NV - Key news
- Koninklijke Philips NV - Key offerings
- Koninklijke Philips NV - Segment focus
- SWOT
14.13 Mallinckrodt Plc
- Mallinckrodt Plc - Overview
- Mallinckrodt Plc - Business segments
- Mallinckrodt Plc - Key news
- Mallinckrodt Plc - Key offerings
- Mallinckrodt Plc - Segment focus
- SWOT
14.14 Medi-Radiopharma
- Medi-Radiopharma - Overview
- Medi-Radiopharma - Product / Service
- Medi-Radiopharma - Key offerings
- SWOT
14.15 Necsa
- Necsa - Overview
- Necsa - Product / Service
- Necsa - Key offerings
- SWOT
14.16 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
14.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
14.18 Sirtex Medical Pty Ltd.
- Sirtex Medical Pty Ltd. - Overview
- Sirtex Medical Pty Ltd. - Product / Service
- Sirtex Medical Pty Ltd. - Key offerings
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits11: Overview on criticality of inputs and factors of differentiation
Exhibits12: Overview on factors of disruption
Exhibits13: Impact of drivers and challenges in 2024 and 2029
Exhibits14: Parent Market
Exhibits15: Data Table on - Parent Market
Exhibits16: Market characteristics analysis
Exhibits17: Value chain analysis
Exhibits18: Offerings of companies included in the market definition
Exhibits19: Market segments
Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Historic Market Size - Data Table on Global Nuclear Medicine Market 2019 - 2023 ($ million)
Exhibits25: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits29: Five forces analysis - Comparison between 2024 and 2029
Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits35: Chart on Market condition - Five forces 2024 and 2029
Exhibits36: Chart on Product - Market share 2024-2029 (%)
Exhibits37: Data Table on Product - Market share 2024-2029 (%)
Exhibits38: Chart on Comparison by Product
Exhibits39: Data Table on Comparison by Product
Exhibits40: Chart on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits41: Data Table on Radiotherapeutics - Market size and forecast 2024-2029 ($ million)
Exhibits42: Chart on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
Exhibits43: Data Table on Radiotherapeutics - Year-over-year growth 2024-2029 (%)
Exhibits44: Chart on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
Exhibits45: Data Table on Equipment (SPECT and PET) - Market size and forecast 2024-2029 ($ million)
Exhibits46: Chart on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
Exhibits47: Data Table on Equipment (SPECT and PET) - Year-over-year growth 2024-2029 (%)
Exhibits48: Market opportunity by Product ($ million)
Exhibits49: Data Table on Market opportunity by Product ($ million)
Exhibits50: Chart on Application - Market share 2024-2029 (%)
Exhibits51: Data Table on Application - Market share 2024-2029 (%)
Exhibits52: Chart on Comparison by Application
Exhibits53: Data Table on Comparison by Application
Exhibits54: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits55: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits56: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits57: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits58: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits59: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits60: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits61: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits62: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits63: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits64: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits65: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits66: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits67: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits68: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits69: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits70: Market opportunity by Application ($ million)
Exhibits71: Data Table on Market opportunity by Application ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits81: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits82: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits83: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits84: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits85: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits86: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits87: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits88: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits93: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits96: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits97: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Australia - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Australia - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Australia - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits133: Market opportunity By Geographical Landscape ($ million)
Exhibits134: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits135: Impact of drivers and challenges in 2024 and 2029
Exhibits136: Overview on criticality of inputs and factors of differentiation
Exhibits137: Overview on factors of disruption
Exhibits138: Impact of key risks on business
Exhibits139: Companies covered
Exhibits140: Company ranking index
Exhibits141: Matrix on companies position and classification
Exhibits142: Bayer AG - Overview
Exhibits143: Bayer AG - Business segments
Exhibits144: Bayer AG - Key news
Exhibits145: Bayer AG - Key offerings
Exhibits146: Bayer AG - Segment focus
Exhibits147: SWOT
Exhibits148: Bracco Spa - Overview
Exhibits149: Bracco Spa - Product / Service
Exhibits150: Bracco Spa - Key offerings
Exhibits151: SWOT
Exhibits152: Cardinal Health Inc. - Overview
Exhibits153: Cardinal Health Inc. - Business segments
Exhibits154: Cardinal Health Inc. - Key news
Exhibits155: Cardinal Health Inc. - Key offerings
Exhibits156: Cardinal Health Inc. - Segment focus
Exhibits157: SWOT
Exhibits158: Eckert and Ziegler AG - Overview
Exhibits159: Eckert and Ziegler AG - Business segments
Exhibits160: Eckert and Ziegler AG - Key news
Exhibits161: Eckert and Ziegler AG - Key offerings
Exhibits162: Eckert and Ziegler AG - Segment focus
Exhibits163: SWOT
Exhibits164: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Overview
Exhibits165: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Product / Service
Exhibits166: ECZACIBASI MONROL NUCLEAR PRODUCTS CO. - Key offerings
Exhibits167: SWOT
Exhibits168: GE Healthcare Technologies Inc. - Overview
Exhibits169: GE Healthcare Technologies Inc. - Business segments
Exhibits170: GE Healthcare Technologies Inc. - Key news
Exhibits171: GE Healthcare Technologies Inc. - Key offerings
Exhibits172: GE Healthcare Technologies Inc. - Segment focus
Exhibits173: SWOT
Exhibits174: IBA Radiopharma Solutions - Overview
Exhibits175: IBA Radiopharma Solutions - Business segments
Exhibits176: IBA Radiopharma Solutions - Key news
Exhibits177: IBA Radiopharma Solutions - Key offerings
Exhibits178: IBA Radiopharma Solutions - Segment focus
Exhibits179: SWOT
Exhibits180: Jubilant Pharmova Ltd. - Overview
Exhibits181: Jubilant Pharmova Ltd. - Business segments
Exhibits182: Jubilant Pharmova Ltd. - Key news
Exhibits183: Jubilant Pharmova Ltd. - Key offerings
Exhibits184: Jubilant Pharmova Ltd. - Segment focus
Exhibits185: SWOT
Exhibits186: Koninklijke Philips NV - Overview
Exhibits187: Koninklijke Philips NV - Business segments
Exhibits188: Koninklijke Philips NV - Key news
Exhibits189: Koninklijke Philips NV - Key offerings
Exhibits190: Koninklijke Philips NV - Segment focus
Exhibits191: SWOT
Exhibits192: Mallinckrodt Plc - Overview
Exhibits193: Mallinckrodt Plc - Business segments
Exhibits194: Mallinckrodt Plc - Key news
Exhibits195: Mallinckrodt Plc - Key offerings
Exhibits196: Mallinckrodt Plc - Segment focus
Exhibits197: SWOT
Exhibits198: Medi-Radiopharma - Overview
Exhibits199: Medi-Radiopharma - Product / Service
Exhibits200: Medi-Radiopharma - Key offerings
Exhibits201: SWOT
Exhibits202: Necsa - Overview
Exhibits203: Necsa - Product / Service
Exhibits204: Necsa - Key offerings
Exhibits205: SWOT
Exhibits206: Novartis AG - Overview
Exhibits207: Novartis AG - Business segments
Exhibits208: Novartis AG - Key news
Exhibits209: Novartis AG - Key offerings
Exhibits210: Novartis AG - Segment focus
Exhibits211: SWOT
Exhibits212: Siemens Healthineers AG - Overview
Exhibits213: Siemens Healthineers AG - Business segments
Exhibits214: Siemens Healthineers AG - Key news
Exhibits215: Siemens Healthineers AG - Key offerings
Exhibits216: Siemens Healthineers AG - Segment focus
Exhibits217: SWOT
Exhibits218: Sirtex Medical Pty Ltd. - Overview
Exhibits219: Sirtex Medical Pty Ltd. - Product / Service
Exhibits220: Sirtex Medical Pty Ltd. - Key offerings
Exhibits221: SWOT
Exhibits222: Inclusions checklist
Exhibits223: Exclusions checklist
Exhibits224: Currency conversion rates for US$
Exhibits225: Research methodology
Exhibits226: Information sources
Exhibits227: Data validation
Exhibits228: Validation techniques employed for market sizing
Exhibits229: Data synthesis
Exhibits230: 360 degree market analysis
Exhibits231: List of abbreviations